Aldeyra Therapeutics (ALDX) Earnings Date & Reports

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALDX is expected to report earnings to rise 87.50% to -11 cents per share on July 31

Aldeyra Therapeutics ALDX Stock Earnings Reports

Q2'26

Est.

$-0.11

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.12

Q2'25

Beat

by $0.08

The last earnings report on April 30 showed earnings per share of -5 cents, beating the estimate of -9 cents. With 2.43M shares outstanding, the current market capitalization sits at 121.85M.

View a ticker or compare two or three

Compare

ALDX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ALDX